Chronic News and Research

RSS
New clinical study reveals previously unknown risk factors linked to keratoconus

New clinical study reveals previously unknown risk factors linked to keratoconus

Loyola neurosurgeon examines issue of hydrocephalus in Uganda

Loyola neurosurgeon examines issue of hydrocephalus in Uganda

New UTMB study reveals link between traumatic brain injury and Alzheimer's disease

New UTMB study reveals link between traumatic brain injury and Alzheimer's disease

New mechanism of differentiation may offer novel therapeutic approaches to blood malignancies, solid tumors

New mechanism of differentiation may offer novel therapeutic approaches to blood malignancies, solid tumors

Apollo Care Connect acquires Healarium's population health management technology and operating platform

Apollo Care Connect acquires Healarium's population health management technology and operating platform

Study examines impact of sit-stand workstations in reducing chronic low back pain in office workers

Study examines impact of sit-stand workstations in reducing chronic low back pain in office workers

OptMed obtains FDA 510(k) marketing clearance for topical skin adhesive

OptMed obtains FDA 510(k) marketing clearance for topical skin adhesive

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

New studies provide insights into impact of vision loss among survivors of childhood cancers

New studies provide insights into impact of vision loss among survivors of childhood cancers

Coordinated care approach to diabetes self-management benefits underserved adult populations

Coordinated care approach to diabetes self-management benefits underserved adult populations

NeuroSky develops cost-effective, secure medical monitoring solution to improve remote patient care

NeuroSky develops cost-effective, secure medical monitoring solution to improve remote patient care

JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

New article suggests that playing American football may contribute to hypertension

New article suggests that playing American football may contribute to hypertension

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

UA researchers find genetic mutations associated with respiratory disease

UA researchers find genetic mutations associated with respiratory disease

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

ACell launches two new wound management devices

ACell launches two new wound management devices

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

Palliative care improves care quality, reduces costs for advanced cancer patients with comorbidities

Palliative care improves care quality, reduces costs for advanced cancer patients with comorbidities

Drexel biomedical engineer identifies immune cell as potential strategy for growing blood vessels

Drexel biomedical engineer identifies immune cell as potential strategy for growing blood vessels

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.